Gene therapy for cancer treatment: past, present and future - Wikidata - wikimedia - TriplyDB

Gene therapy for cancer treatment: past, present and future

Gene therapy for cancer treatment: past, present and future

http://www.wikidata.org/entity/Q35040146

about

The history of tumor virology Toxin-based therapeutic approaches Synthetic biology and occupational risk Ultrasound-targeted microbubble destruction to deliver siRNA cancer therapy.Multifaceted Applications of Chitosan in Cancer Drug Delivery and Therapy.Downregulation of calbindin 1, a calcium-binding protein, reduces the proliferation of osteosarcoma cells.Polymeric Nanoparticle-Mediated Gene Delivery for Lung Cancer Treatment.Epidemiology of lung cancer prognosis: quantity and quality of life.Gene therapy in pancreatic cancer.SSTR2-based reporters for assessing gene transfer into non-small cell lung cancer: evaluation using an intrathoracic mouse model.Gene transfection efficacy assessment of human cervical cancer cells using dual-mode fluorescence microendoscopy Immunotherapy for lung cancers.A novel oncolytic herpes simplex virus type 2 has potent anti-tumor activity DNA Polymerases as targets for gene therapy of hepatocellular carcinoma.Decitabine immunosensitizes human gliomas to NY-ESO-1 specific T lymphocyte targeting through the Fas/Fas ligand pathway.Genetic control of wayward pluripotent stem cells and their progeny after transplantation.Gene therapy for malignant glioma.Self-assembled mPEG-PCL-g-PEI micelles for simultaneous codelivery of chemotherapeutic drugs and DNA: synthesis and characterization in vitro.Pinellia pedatisecta agglutinin interacts with the methylosome and induces cancer cell death.Immune cell recruitment and cell-based system for cancer therapy.Plasmid CpG depletion improves degree and duration of tumor gene expression after intravenous administration of polyplexes.Medical technologies for the diagnosis of prostate cancer.Intrabody strategies for the treatment of human papillomavirus-associated disease.Overview of targeted therapies in oncology.Wnt5A regulates expression of tumor-associated antigens in melanoma via changes in signal transducers and activators of transcription 3 phosphorylation.Intratumoral epidermal growth factor receptor antisense DNA therapy in head and neck cancer: first human application and potential antitumor mechanisms Immune-mediated anti-neoplastic effect of intratumoral RSV envelope glycoprotein expression is related to apoptotic death of tumor cells but not to the size of syncytia "Marker of Self" CD47 on lentiviral vectors decreases macrophage-mediated clearance and increases delivery to SIRPA-expressing lung carcinoma tumors Therapeutic evaluation of Epstein-Barr virus-encoded latent membrane protein-1 targeted DNAzyme for treating of nasopharyngeal carcinomas.Pharmaceutical emulsions: a new approach for gene therapy.Co-expression of perforin and granzyme B genes induces apoptosis and inhibits the tumorigenicity of laryngeal cancer cell line Hep-2.Immunotherapeutic strategies for cancer treatment: a novel protein transfer approach for cancer vaccine development.Advance in herpes simplex viruses for cancer therapy.An overview of gene therapy in head and neck cancer.Engineering Stem Cells for Biomedical Applications.Adeno-associated virus (AAV) vectors in cancer gene therapy.Tumor suppressor NGX6 inhibits the growth and metastasis of multiple cancers.Gene therapy as a potential tool for treating neuroblastoma-a focused review.Gene therapy for ovarian cancer using carbonyl reductase 1 DNA with a polyamidoamine dendrimer in mouse models.Garcinol inhibits tumour cell proliferation, angiogenesis, cell cycle progression and induces apoptosis via NF-κB inhibition in oral cancer.

P2860

Q24610004-FCF0809C-15F5-4000-85A2-C500E31CDC0C Q27013664-F27354BF-3C1E-46C3-88DB-AC46C26AF9B9 Q27968974-D1571BC3-C61A-402C-9FCF-21521CE70D5D Q30446500-51857F55-A968-422A-AD90-EB86269B6C03 Q33612179-303B720A-A498-4257-815E-A83984594435 Q33686136-3925671B-8C5A-4631-8DDC-6ACD47F12455 Q33824400-C74100A0-F54D-41D3-9B51-0199EE13F41F Q34135295-B91F2F18-9999-46AF-802C-648905E6A6E6 Q34302954-7B3543BE-6027-4B8E-BD82-B2560820F0DC Q34511795-9C295D1E-3600-49CD-B677-09F77FDD1D4B Q34543520-26FF0DB7-2357-4EB7-BA6F-F1E84AC00906 Q34557611-6C3C72EB-853A-45B6-B898-A1AA540D0082 Q35132272-378BE505-D2D9-47E5-A423-DB27AC14B962 Q35579189-0A4E4F4F-39AB-474D-8E02-A563EF928A85 Q35589288-411ADF05-9F39-4B27-826B-1F4D926E8AED Q35661899-CB0E0815-A58B-4D86-89A2-A531F15F2919 Q35673628-26DCE07B-6B33-410D-8DD1-897AA89DE8BF Q35972548-4F0911F5-2C31-4A96-816F-2C65B5E04267 Q36415119-65373F75-5F03-460D-9179-C3A08B5C4972 Q36517706-C0920C43-6DA8-42C4-B56C-7CFF56039AA9 Q36738246-DDB8CF1B-DE0A-49BD-8AE0-CE8CFDF091F5 Q36759527-F7C58960-0A54-4FF0-A107-A6220E2DF502 Q36810292-C4AC6993-B91F-48E9-A3CA-C7CB3D0EAF87 Q37018324-D884257C-1025-41FB-935C-84DBB4568925 Q37020867-6E47B5D9-34C0-4A04-9DC8-BD8F04C604CB Q37155639-88852E23-2871-4625-AD24-B87D24948485 Q37240366-054D266A-CAF5-4E03-B6A8-771106BF6BC8 Q37490583-7B70501F-DD92-4554-9146-FC778923BBE5 Q37562093-5BF29679-2345-4A79-8714-6A21A2F536E7 Q37643683-C31B85D0-A02D-4795-AD6B-EDC848705494 Q37676738-98849D4E-5E8F-4685-8014-0B02D82D69D6 Q38051534-95FA8791-5C2B-4C6C-BD61-5128750CAEC8 Q38096940-17D02B8E-0091-4BE0-A9D6-DDE35501286A Q38171470-5BBE5A8F-27D8-4FA7-A503-8CD928CBB2EE Q38378499-EFB4F6FA-F5F6-4692-A142-184F79490B93 Q38706321-524708FF-31E6-407B-A56A-37DAFD000A85 Q38735079-74A00EBC-447C-4A8B-A921-3F8765AD59D1 Q38808728-42091CE2-4EBE-4F78-9E34-9C08955355ED Q38818448-0769B3F9-12BC-421E-8C3E-E25B5B547CC3 Q38862175-89760F64-1CF1-4A76-A732-9BA43D4F8918

P2860

Gene therapy for cancer treatment: past, present and future

http://www.wikidata.org/entity/Q35040146

description

2006 nî lūn-bûn

@nan

2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Gene therapy for cancer treatment: past, present and future

@ast

Gene therapy for cancer treatment: past, present and future

@en

type

label

Gene therapy for cancer treatment: past, present and future

@ast

Gene therapy for cancer treatment: past, present and future

@en

prefLabel

Gene therapy for cancer treatment: past, present and future

@ast

Gene therapy for cancer treatment: past, present and future

@en

P1433

Q35040146-EB25A3F7-5CC2-4516-AA1E-9E8C16E6DB4B

P1476

Q35040146-D5272F4F-4455-43A9-842E-E13F29A97300

P2093

Q35040146-63B02BAE-CA9A-4DB3-B205-C95F1B3DAEE0

Q35040146-9F4C0C31-D305-445B-83EC-51C6D1BE2079

P2860

Q35040146-01335F0C-3E5C-4728-B362-E39225524FEC

Q35040146-01E6C6E7-08B6-4DD3-862E-4190FC29FE89

Q35040146-0B967A1E-D264-43B2-849B-AA7833F0BC32

Q35040146-0C5EB26D-9683-40B9-9499-9173CBC24A96

Q35040146-0D8CDDF5-51CD-4E1B-AB80-A1B643100CFA

Q35040146-0ED1D73A-16CF-425E-A898-E7879D6D8148

Q35040146-1C01480A-E720-4454-8268-AD5763E5EA71

Q35040146-2536898A-336A-4C77-9CCB-1AB0B8F45BFF

Q35040146-29679668-9BDC-4F47-A8CF-FF459EFAA9C6

Q35040146-2CC97B74-98E9-4F2B-948E-1746897DDC34

P304

Q35040146-E2B8D335-3361-4057-8701-15CED527CBC9

P31

Q35040146-676580BF-1EC4-4427-BB24-E7A5980D3D8C

P356

Q35040146-A0E51E08-FF49-44E0-BA44-F476A03C025B

P433

Q35040146-DECA8138-7512-447D-B2B0-A56EDF1BA19E

P478

Q35040146-E8DD7AC4-CB81-4C5B-9CDA-D907F54D2DB2

P577

Q35040146-EB4860F9-3931-41E1-BD86-9E7477DE608A

P5875

Q35040146-70C047E0-6D10-4683-BB2D-57956D8A20E2

P698

Q35040146-D5D7F132-1858-4CA7-83AD-35776825BB9C

P921

Q35040146-CB34F28B-BC69-420B-8945-E319BBED919B

P932

Q35040146-132210D5-DB6A-426D-9AF2-BBD7AB53314D

P356

P1433

Clinical Medicine and Research

P1476

Gene therapy for cancer treatment: past, present and future

@en

P2093

Deanna Cross

http://www.w3.org/2001/XMLSchema#string

James K Burmester

http://www.w3.org/2001/XMLSchema#string

P2860

Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer

p53: an overview of over two decades of study.

Elevated activated partial thromboplastin time during administration of first-generation adenoviral vectors for gene therapy for prostate cancer: identification of lupus anticoagulants.

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial.

Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trial.

Viral oncolysis.

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells.

Clinical evaluation of adenoviral-mediated p53 gene transfer: review of INGN 201 studies.

Sleeping beauty transposon-mediated gene therapy for prolonged expression.

Genetically modified tumour vaccines: an obstacle race to break host tolerance to cancer.

P304

218-227

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3121/CMR.4.3.218

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2006-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6806526

http://www.w3.org/2001/XMLSchema#string

P698

16988102

http://www.w3.org/2001/XMLSchema#string

P921

P932

1570487

http://www.w3.org/2001/XMLSchema#string